tiprankstipranks
Advertisement

ELCV - ETF AI Analysis

Compare

Top Page

ELCV

Eventide High Dividend ETF (ELCV)

Rating:69Neutral
Price Target:
ELCV, the Eventide High Dividend ETF, earns a solid overall rating thanks to several strong core holdings like Medtronic, Huntington Bancshares, Royalty Pharma, Amgen, and Exxon Mobil, which all show healthy financial performance, supportive earnings calls, and generally positive growth or income prospects. These strengths are partly offset by holdings such as Entergy and Home Depot, where high leverage, weaker technical trends, and cash flow concerns introduce more risk. The main risk factor for the fund is its exposure to companies with elevated debt and some signs of overvaluation or bearish momentum, which could increase volatility if market conditions worsen.
Positive Factors
Strong Recent Performance
The ETF has shown solid gains over the past year-to-date, three-month, and one-month periods, indicating positive recent momentum.
Leading Holdings Performing Well
Several of the largest positions, including major energy, industrial, and healthcare names, have delivered strong year-to-date results that support the fund’s overall returns.
Income-Focused Sector Mix
Heavy exposure to traditionally higher-dividend areas like energy, utilities, and real estate aligns with the fund’s high-dividend objective and can help support income-focused investors.
Negative Factors
Higher-Than-Average Fees
The expense ratio is on the higher side for an ETF, which means more of the fund’s returns are used to cover costs instead of going to investors.
Concentration in a Few Sectors
Large weights in energy and utilities increase the fund’s sensitivity to downturns or regulatory changes in these specific industries.
Limited Geographic Diversification
With almost all assets invested in U.S. companies, the fund offers little exposure to international markets, which can reduce diversification benefits.

ELCV vs. SPDR S&P 500 ETF (SPY)

ELCV Summary

The Eventide High Dividend ETF (ELCV) is an exchange-traded fund that focuses on U.S. companies paying relatively high dividends, aiming to provide investors with a steady income stream. It does not track a specific index, but instead selects a mix of stocks across many sectors, including energy, utilities, technology, and health care. Well-known holdings include Exxon Mobil, Home Depot, Amgen, and Caterpillar. Someone might invest in ELCV to seek regular dividend income along with potential long-term growth. A key risk is that stock prices and dividend payments can go up and down with the overall market and specific sectors like energy and utilities.
How much will it cost me?The Eventide High Dividend ETF (ELCV) has an expense ratio of 0.49%, meaning you’ll pay $4.90 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, focusing on selecting high-dividend stocks to maximize income and growth potential.
What would affect this ETF?The Eventide High Dividend ETF (ELCV) could benefit from stable or rising interest in dividend-paying stocks, particularly in sectors like Utilities and Energy, which are traditionally resilient during economic uncertainty. However, it may face challenges if interest rates rise significantly, as higher rates can make dividend-focused investments less attractive compared to fixed-income alternatives. Additionally, sector-specific risks, such as regulatory changes in Energy or Financials, could impact performance.

ELCV Top 10 Holdings

ELCV leans heavily on U.S. dividend payers in energy, utilities, and real assets, and its recent story is more about steady income with a few standout engines. Caterpillar has been powering ahead, with Royalty Pharma and Entergy also rising and giving the fund some extra lift. Prologis has been quietly supportive, adding a stable real estate backbone. On the flip side, Exxon Mobil and Williams have seen more mixed momentum, while Home Depot looks like it’s catching its breath. Overall, the fund is concentrated in North American, cash-generating workhorses rather than high-flying growth names.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Prologis5.36%$10.99M$135.56B35.52%
76
Outperform
Entergy4.87%$10.00M$52.02B33.32%
66
Neutral
Williams Co3.92%$8.05M$88.27B20.03%
76
Outperform
Amgen3.75%$7.70M$185.95B20.17%
77
Outperform
Exxon Mobil3.48%$7.14M$618.95B36.42%
74
Outperform
GE Vernova Inc.3.31%$6.80M$308.81B202.72%
69
Neutral
Home Depot3.30%$6.78M$334.56B-6.90%
66
Neutral
Royalty Pharma3.23%$6.62M$28.49B52.58%
79
Outperform
Huntington Bancshares3.09%$6.35M$33.41B13.37%
80
Outperform
Enbridge3.09%$6.34M$116.58B12.46%

ELCV Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
29.48
Positive
100DMA
28.52
Positive
200DMA
27.32
Positive
Market Momentum
MACD
0.42
Negative
RSI
67.40
Neutral
STOCH
83.69
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ELCV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 30.11, equal to the 50-day MA of 29.48, and equal to the 200-day MA of 27.32, indicating a bullish trend. The MACD of 0.42 indicates Negative momentum. The RSI at 67.40 is Neutral, neither overbought nor oversold. The STOCH value of 83.69 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ELCV.

ELCV Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$220.73M0.49%
69
Neutral
$735.24M0.50%
72
Outperform
$225.68M0.59%
69
Neutral
$176.50M0.35%
72
Outperform
$72.97M0.35%
70
Outperform
$36.17M0.40%
65
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ELCV
Eventide High Dividend ETF
30.86
7.12
29.99%
FDV
Federated Hermes U.S. Strategic Dividend ETF
TBG
TBG Dividend Focus ETF
HIDV
AB US High Dividend ETF
FDIV
MarketDesk Focused U.S. Dividend ETF
PAYR
Federated Hermes Enhanced Income ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement